Catalyst Biosciences, Inc. Stock

Market capitalization is the stock price multiplied by the number of shares issued.

Catalyst Biosciences, Inc.

Enterprise value (EV) is a measure of the value of a company regardless of its financing. It is calculated as follows:
EV = market capitalization - cash + debt.

Enterprise Value metric explained

Catalyst Biosciences, Inc.

The P/E ratio or price/earnings ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to earnings per share.

Catalyst Biosciences, Inc.

The P/B ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to the book value per share.

Catalyst Biosciences, Inc.

The current dividend yield is calculated as the quotient of the last annual dividend and the last closing price. Special dividends are not included in the calculation.

Catalyst Biosciences, Inc.

A dividend represents the distribution of profits to shareholders.

Catalyst Biosciences, Inc.

Sales growth TTM (Trailing Twelve Months) compares the sales of the last 12 months with the sales of the previous 12 months.

Catalyst Biosciences, Inc.

Revenue TTM (Trailing Twelve Months) represents the sum of all revenues of a company for its products, services or other items within the last 12 months.

Catalyst Biosciences, Inc.

EBIT or the operating result represents the profit or loss after deducting direct costs (cost of sales), sales, marketing, administrative, research and development costs and depreciation and amortization.

Catalyst Biosciences, Inc.

Cash is defined as cash and cash equivalents (i.e. cash items of very high value).

Catalyst Biosciences, Inc.

EPS TTM (Trailing Twelve Months) or earnings per share represents the profit per share over the last 12 months. The company's net profit is divided by the number of shares.

Catalyst Biosciences, Inc.

Price/earnings ratio based on the expected net earnings per share for the financial year ending at Dec 31 2024.

Catalyst Biosciences, Inc.

Ratio of market capitalization to sales on the basis of expected sales for the financial year ending at Dec 31 2024

Catalyst Biosciences, Inc.

Ratio of enterprise value to sales based on estimated sales for the financial year ending at Dec 31 2024

Catalyst Biosciences, Inc.